Need some advice?
+33(0)4 77 74 51 11 | Mail

Covid-19: we stand by you at 04 77 74 51 11 or dtf.export@dtf.fr

Antigenic test on nasopharyngeal sample - COVID-19

BTE25ANTIGENN

Immunochromatographic test designed for the qualitative detection of SARS-CoV-2 specific antigen in a human nasopharyngeal swab specimen. It is intended to be used by professionals as a screening test and as an aid in the early diagnosis of SARS-CoV-2 infection.

SARS-CoV-2 infection.

  • French design and manufacture
  • Rapid and reliable detection of SARS-CoV-2 antigens:
    Results in 15 minutes
    Sensitivity: 98.8%; Specificity: 100.0
    Detects N protein and new variants of COVID-19 virus.
  • Convenient to use:
    No additional equipment required, can be performed in the clinic.
    Can also be used to support public health strategies, such as contact tracing and large-scale testing of people suspected of having an active infection.
  • Sold in boxes of 25 units
  • Contents of one box :
    25 swabs
    25 COVID-19 rapid test cassettes packaged in an individual foil pouch
    1 bottle of extraction buffer
    25 extraction tubes and dropper caps
    Instructions for use

Listed by the French Ministry of Health.

  • CE
  • IVD

More details

Advantages of the product:

  • French design and manufacture
  • Fast and reliable detection
  • Practice to use
  • Eligible for reimbursement and listed by the Ministry of Health
Haut de page
CharacteristicValue
PackagingBox of 25 kits

In-vitro diagnostic medical device.

In vitro diagnostic medical devices. Classification: Other tests. Read carefully the instructions in the leaflet accompanying the medical device. According to the notice n° 2021.0015/AC/SEAP of 15 March 2021, the test is intended for in vitro diagnostic use for professional use. Documentation intended for the health professional. Photographs are not contractual.

Haut de page